Proteomics in diabetes and heart disease therapies
|Led by Profs. Garth Cooper & Peter Hunter|
This component of the CoRE focuses on the development of advanced proteomics for the identification of proteins and peptides that can either be developed as therapeutics in their own right or provide targets for structure-based drug design. The main goal is to identify new peptide therapeutics for diabetes and heart disease and to develop advanced mass spectrometry techniques for large scale proteomic analysis of major cell types involved in fuel metabolism.